MktsMarkets

InspireMD Inc.
NASDAQ: NSPRKey statistics
NSPR News
Stories mentioning NSPR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 3,398 | 3,149 | 2,523 | 1,778 | 1,529 | 1,949 | 1,810 | 1,739 |
| Cost of Goods Sold | 2,711 | 1,969 | 1,659 | 1,465 | 1,237 | 1,480 | 1,396 | 1,408 |
| Gross Profit | 687.00 | 1,180 | 864.00 | 313.00 | 292.00 | 469.00 | 414.00 | 331.00 |
| Operating Expenses | ||||||||
| Research & Development | 4,763 | 3,475 | 3,635 | 3,834 | 4,059 | 3,693 | 3,915 | 3,401 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 14,665 | 13,264 | 13,915 | 13,332 | 11,752 | 9,836 | 8,876 | 8,591 |
| Operating Income (Loss) | (13,978) | (12,084) | (13,051) | (13,019) | (11,460) | (9,367) | (8,462) | (8,260) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (13,689) | (11,761) | (12,708) | (13,151) | (11,166) | (9,174) | (7,890) | (7,909) |
| Earnings Per Share (Basic) | (0.16) | (0.18) | (0.17) | (0.26) | 0.22 | (0.22) | (0.16) | (0.22) |
| Earnings Per Share (Diluted) | (0.16) | (0.18) | (0.17) | (0.26) | 0.22 | (0.22) | (0.16) | (0.22) |
| Weighted Average Shares Outstanding (Basic) | 83,802 | 64,326 | 73,467 | 51,004 | 49,994 | 41,928 | 48,369 | 35,878 |
| Weighted Average Shares Outstanding (Diluted) | 83,802 | 64,326 | 73,467 | 51,004 | 49,994 | 41,928 | 48,369 | 35,878 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NSPR
InspireMD Inc. (NASDAQ: NSPR) is a stock listed on the Nasdaq Stock Market under the ticker symbol NSPR. It last traded at $0.7000 (Nov 6, 2026, 9:30 AM ET), up 9.4% on the day. That gives InspireMD a market capitalisation of $36.3M.
Over the past 52 weeks NSPR has traded between $0.4300 and $2.22.
Revenue for the quarter ended Mar 31, 2026 was $3.4M; a net loss of $13.7M. Revenue was up 122% from $1.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $3.4M | -$13.7M | -402.9% |
| Dec 31, 2025 | $3.1M | -$11.8M | -373.5% |
| Sep 30, 2025 | $2.5M | -$12.7M | -503.7% |
| Jun 30, 2025 | $1.8M | -$13.2M | -739.7% |
From InspireMD’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…